Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-08
2006-08-08
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S302000, C544S127000, C546S115000
Reexamination Certificate
active
07087601
ABSTRACT:
Phenyl compounds substituted at the 1-position with a fused bicyclo moeity formed from a five-membered heterocycle fused to a six-membered carbocycle, to a six-membered aryl, or to a six-membered hetaryl, and further optionally substituted at the 3,4 positions, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, and panic, as well as in the treatment of pain and other diseases.
REFERENCES:
patent: 3458506 (1969-07-01), Bloom et al.
patent: 3899506 (1975-08-01), Shen et al.
patent: 4038396 (1977-07-01), Shen et al.
patent: 5077408 (1991-12-01), Guillaumet et al.
patent: WO 96 11917 (1996-04-01), None
patent: WO 02 51821 (2002-07-01), None
Bathini et al., “A convenient synthesis of substituted oxazolo[5,4-b]pyridines using lead tetraacetate as oxidative cyclizing agent,” Synthetic Communications (1991), 21(2), 215-22.
Flouzat et al., “A new convenient synthesis of 2-aryl- and 2-heteroaryloxazolo[5,4-b]pyridines,” Synthesis (1990), (1), 64-6.
Frazer et al., “Oxazolopyridines and oxazoloquinolines. I. 2′-Alkyland 2′-aryl derivatives of oxazolo[4′,5′,3,4]pyridine and oxazolo[4′,5′,3,4]quinoline,” Journal of the Chemical Society, Abstracts (1956), 1781-4.
Bathini, et al., Synthetic Communications, vol. 21 (2), pp. 215-22, 1991.
Flouzat, et al., Synthesis, vol. 1, pp. 64-6, 1990.
Frazer, et al., Journal of the Chemical Society, Abstracts, pp. 1781-4, 1956.
Arruda Jeannie
Bonnefous Celine
Campbell Brian T.
Cube Rowena V.
Munoz Benito
Freistein Andrew B.
Merck & Co. , Inc.
Rose David L.
Rubin David A.
Solola Taofiq
LandOfFree
Metabotropic glutamate receptor-5 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metabotropic glutamate receptor-5 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabotropic glutamate receptor-5 modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714411